1. Corrigendum to "Enhanced Remyelination Following Lysolecithin-induced Demyelination in Mice Under Treatment with Fingolimod (FTY720)" [Neuroscience 311 (2015) 34–44]. (1st July 2021) Authors: Yazdi, A.; Baharvand, H.; Javan, M. Journal: Neuroscience Issue: Volume 466(2021) Page Start: 310 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Enhanced remyelination following lysolecithin-induced demyelination in mice under treatment with fingolimod (FTY720). (17th December 2015) Authors: Yazdi, A.; Baharvand, H.; Javan, M. Journal: Neuroscience Issue: Volume 311(2015) Page Start: 34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Evaluation of the COVID-19 pandemic effect on the development of somatic symptoms in patients with mood disorders: a case-control study. (September 2021) Authors: Shahini, N.; Ghasemzadeh, M.; Javan, M.; Salimi, Z. Journal: New microbes and new infections Issue: Volume 43(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Oct4 transcription factor in conjunction with valproic acid accelerates myelin repair in demyelinated optic chiasm in mice. (24th March 2016) Authors: Dehghan, S.; Hesaraki, M.; Soleimani, M.; Mirnajafi-Zadeh, J.; Fathollahi, Y.; Javan, M. Journal: Neuroscience Issue: Volume 318(2016) Page Start: 178 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Oct4 transcription factor in conjunction with valproic acid accelerates myelin repair in demyelinated optic chiasm in mice. (24th March 2016) Authors: Dehghan, S.; Hesaraki, M.; Soleimani, M.; Mirnajafi-Zadeh, J.; Fathollahi, Y.; Javan, M. Journal: Neuroscience Issue: Volume 318(2016) Page Start: 178 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗